Beta site/ Site under maintenance
Profile Photo

Dr. Nishil B.A , MBBA

Nishit Care

5 Years Experience

Professional Summary Dr. Nishil is a highly accomplished Gastroenterologist and Hepatologist based in Ahmedabad, Gujarat, with specialized expertise in digestive health, liver diseases, and advanced endoscopic procedures. Dr. Nishil is renowned for his comprehensive approach to gastrointestinal disorders, therapeutic endoscopy, and inflammatory bowel disease management, providing patient-centred care through evidence-based treatment protocols.

Hospital Affiliations:
Marengo CIMS Hospital, Ahmedabad

Hospital Features:

Multi-specialty tertiary care hospitals
Advanced endoscopy suites
State-of-the-art diagnostic facilities
Comprehensive gastroenterology services  

Yrs

Male

Female

Other

Attachment
    This is content box Two

    Date: 05 Nov 2025

    1. Nature of Services
      • I understand that Reopine is a technology platform that connects me with independent, licensed doctors in India for medical opinion/teleconsultation.
      • I acknowledge that Reopine itself does not provide medical services, diagnosis, or treatment. All medical advice is given solely by the consulting doctor.
    2. Teleconsultation Limitations
      • I understand that teleconsultation has inherent limitations compared to in-person consultation, including lack of physical examination and limited access to diagnostic tests.
      • I agree that the medical opinion provided may be limited by the information, history, and documents I provide.
    3. Emergency Situations
      • I acknowledge that Reopine is not to be used in emergency or life-threatening situations.
      • In case of emergencies, I shall immediately contact local healthcare providers or emergency numbers (e.g., 108 in India / 911 in USA).
    4. Cross-Border Consultations
      • I understand that all doctors on Reopine are licensed to practice in India only.
      • If I access the platform from outside India:
        • I agree that the consultation is deemed to have occurred in India under Indian law.
        • I accept full responsibility for compliance with my country’s local laws.
        • I waive any claim against Reopine in foreign jurisdictions.
      • The information provided during this consultation is for general health guidance and educational purposes only.
      • It is not a substitute for an in-person medical examination by a doctor licensed in your country.
      • The doctor may offer advice or general treatment options based on information you share, but you are strongly advised to:
        • Consult a locally licensed physician before starting or changing any medication or treatment.
      • The consultation is conducted based on good faith, relying on the accuracy and completeness of the information you provide.
    5. Data Privacy
      • I consent to Reopine collecting, processing, and storing my personal and medical information in accordance with its Privacy Policy and applicable Indian data protection laws.
      • I understand that my health records may be shared with consulting doctors for the purpose of the consultation.
    6. Payment, Refund & Liability
      • I understand that payments made are subject to Reopine’s Cancellation & Refund Policy.
      • I agree that Reopine’s liability, if any, shall be limited to the amount of service fees paid by me for the disputed consultation, and not exceeding INR 10,000 in any case.
      • I acknowledge that any malpractice or negligence claim lies against the individual doctor, not against Reopine.
    7. Consent & Acknowledgment

      By proceeding, I confirm that:

      1. I have read and understood the Terms & Conditions and this Consent Form.
      2. I voluntarily consent to teleconsultation via Reopine.
      3. I release Reopine from liability for outcomes beyond its control, including medical opinions of independent doctors, third-party technology failures, or my own failure to follow medical advice.

    Patient’s Full Name:

    Signature: ____________________________

    Date: 05 Nov 2025

    Subcribe to our Newsletter

    Subscribe for Updates: Stay informed about the latest investor updates, financial results, and announcements by subscribing to our newsletter.